Theralase Technologies IncTheralase Technologies Inc - ESG Rating & Company Profile powered by AI

Industry Group:Advanced Medical Equipment & Technology

This webpage is a zero-cost Sustainability analysis for Theralase Technologies Inc. Other corporations in the scoring peer group for Theralase Technologies Inc are shown below. The assessment of Theralase Technologies Inc is prepared by All Street Sevva using proprietary NLP.

Theralase Technologies Inc in the Advanced Medical Equipment & Technology industry gained a UN SDG ESG Transparency Score of 3.6; made up of an environmental score of 0.0, social score of 8.0 and governance score of 2.7.

SDG Transparency Score for Theralase Technologies Inc 

3.6

Low Impact
0 - 3
Medium
4 - 6
High
7 - 10
Last Score Update: 2024-05-01
What drives the score for Theralase Technologies Inc 
0.0

Environmental

8.0

Social

2.7

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Calmark Sweden AB
8.0
High
1CHC Healthcare Group
8.0
High
.........
158Cambridge Cognition Holdings PLC
3.7
Medium
158ABIOMED Inc
3.7
Medium
160Theralase Technologies Inc
3.6
Medium
160Neodynamics AB (publ)
3.6
Medium
160Nano-X Imaging Ltd
3.6
Medium
.........
260Zhuhai Hokai Medical Instruments Co Ltd
0.0
Low
260Zynex Inc
0.0
Low
.........
View the full peer group of 456 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Theralase Technologies Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Theralase Technologies Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Theralase Technologies Inc report the average age of the workforce?

LockedSign up for free to unlock

Does Theralase Technologies Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Theralase Technologies Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Theralase Technologies Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does Theralase Technologies Inc offer flexible work?

LockedSign up for free to unlock

Does Theralase Technologies Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Theralase Technologies Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Theralase Technologies Inc conduct supply chain audits?

LockedSign up for free to unlock

Does Theralase Technologies Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Theralase Technologies Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Theralase Technologies Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Theralase Technologies Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Theralase Technologies Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Theralase Technologies Inc disclose water use targets?

LockedSign up for free to unlock

Does Theralase Technologies Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Theralase Technologies Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does Theralase Technologies Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does Theralase Technologies Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Theralase Technologies Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Theralase Technologies Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does Theralase Technologies Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Theralase Technologies Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Theralase Technologies Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Theralase Technologies Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Theralase Technologies Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Theralase Technologies Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Theralase Technologies Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Theralase Technologies Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Theralase Technologies Inc disclose its waste policy?

LockedSign up for free to unlock

Does Theralase Technologies Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does Theralase Technologies Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Theralase Technologies Inc disclose energy use targets?

LockedSign up for free to unlock

Does Theralase Technologies Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Theralase Technologies Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Theralase Technologies Inc
These potential risks are based on the size, segment and geographies of the company.

Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds (PDCs) and their associated drug formulations to treat cancer, bacteria, and viruses in Canada, the United States, and internationally. It also designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions. In addition, the company develops TLD-1433, which is in Phase II for the treatment of Bacillus Calmette Guérin - Unresponsive Carcinoma In-Situ non-muscle invasive bladder cancer. Further, its product candidates include TLC-2000, a superpulsed and visible red laser technology accelerates healing by reducing pain and inflammation while staying below the Maximal Permissible Exposure limit for tissue, as well as related accessories. Additionally, it provides controller-less cool laser therapy systems comprising TLC-900, TLC-300, and TLC-100. The company has research agreements with the University of Manitoba Medical Microbiology department for the development of a coronavirus vaccine and therapy; and the National Microbiology Laboratory and Public Health Agency of Canada for the research and development of a Canadian-based SARS-CoV-2 vaccine. It sells its products to healthcare practitioners. Theralase Technologies Inc. was founded in 1994 and is based in Toronto, Canada.

Sorry!

Failed to process!